◆BLACKSPECTER AI Chat öffnen →

BlackSpecter›Aktien›AMGN

AMGN (AMGN)

Kennzahlen

Marktkapitalisierung

n/a

KGV (TTM)

n/a

Umsatz (TTM)

n/a

EBITDA

n/a

Dividendenrendite

n/a

52W Hoch

n/a

52W Tief

n/a

Beta

n/a

EPS (TTM)

n/a

Forward KGV

n/a

PEG Ratio

n/a

Short-Quote

n/a

Analysten-Ratings

Keine Analysten-Daten verfügbar

Earnings

Keine Earnings-Daten verfügbar

Aktuelle News

Motley Fool·vor 17 Std.

Amgen vs. Axsome Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?

Simply Wall St.·vor 2 Tagen

AstraZeneca (LSE:AZN) Reports Positive TEZSPIRE Phase 3 Results, Is The Discount Too Wide?

Trefis·vor 2 Tagen

Amgen Stock Signals Its Confidence. The Market Agrees.

Investor's Business Daily·vor 2 Tagen

Amgen, AstraZeneca Score With Tezspire; Can They Take On Dupixent?

GuruFocus.com·vor 2 Tagen

AstraZeneca Stock Remains 14% Lower Despite Tezspire Phase 3 Success

Zacks·vor 2 Tagen

AZN/AMGN's Tezspire Hits Primary Goal in Eosinophilic Esophagitis Study

Frag BlackSpecter AI über AMGN

Earnings-Analyse, Bewertungs-Check, Peer-Vergleich — in Sekunden.

Ist AMGN kaufenswert?AMGN Earnings Analyse AMGN Bewertung

AI Chat öffnen →